What question did this study set out to answer?

This study aims to characterize the transcriptomic landscape of HIV-associated diffuse large B-cell lymphoma (DLBCL) to identify distinct subtypes and deregulated pathways.

June 6, 2026Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

Transcriptomic Study of Diffuse Large B-Cell Lymphoma Associated with HIV Infection: Identification of Novel Molecular Subtypes

View Full Paper

Ask AI

Bookmark

This study aims to characterize the transcriptomic landscape of HIV-associated diffuse large B-cell lymphoma (DLBCL) to identify distinct subtypes and deregulated pathways.
Analyzed twelve formalin-fixed, paraffin-embedded DLBCL samples from HIV-positive patients using Agilent’s microarray.
Performed quantile normalization and unsupervised hierarchical clustering based on gene expression profiles.
Identified two distinct transcriptomic subgroups of HIV-associated DLBCL.
Overexpression of TP53 and BCL7A in cluster I, BCL2 in cluster II.
The 'immune system development' pathway was underexpressed in cluster I compared to cluster II.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized trial identifies distinct molecular subtypes in HIV-related DLBCL, suggesting implications for targeted therapies.

Cite This Study

Labiad et al. (2026) studied this question.

synapsesocial.com/papers/6a23baa771a5da9775e765de https://doi.org/10.32604/or.2026.076241

View Full Paper

Ask AI

Bookmark

Transcriptomic Study of Diffuse Large B-Cell Lymphoma Associated with HIV Infection: Identification of Novel Molecular Subtypes

Key Points

Discussion

Implication

Cite This Study

Transcriptomic Study of Diffuse Large B-Cell Lymphoma Associated with HIV Infection: Identification of Novel Molecular Subtypes

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading